JP2017503024A5 - - Google Patents

Download PDF

Info

Publication number
JP2017503024A5
JP2017503024A5 JP2016562455A JP2016562455A JP2017503024A5 JP 2017503024 A5 JP2017503024 A5 JP 2017503024A5 JP 2016562455 A JP2016562455 A JP 2016562455A JP 2016562455 A JP2016562455 A JP 2016562455A JP 2017503024 A5 JP2017503024 A5 JP 2017503024A5
Authority
JP
Japan
Prior art keywords
group
formula
member selected
cyano
independently selected
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016562455A
Other languages
English (en)
Japanese (ja)
Other versions
JP6626454B2 (ja
JP2017503024A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2014/072291 external-priority patent/WO2015103060A1/en
Publication of JP2017503024A publication Critical patent/JP2017503024A/ja
Publication of JP2017503024A5 publication Critical patent/JP2017503024A5/ja
Application granted granted Critical
Publication of JP6626454B2 publication Critical patent/JP6626454B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016562455A 2014-01-06 2014-12-23 Trpa1モジュレーター Active JP6626454B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201461924119P 2014-01-06 2014-01-06
US61/924,119 2014-01-06
PCT/US2014/072291 WO2015103060A1 (en) 2014-01-06 2014-12-23 Trpa1 modulators

Publications (3)

Publication Number Publication Date
JP2017503024A JP2017503024A (ja) 2017-01-26
JP2017503024A5 true JP2017503024A5 (enExample) 2018-02-08
JP6626454B2 JP6626454B2 (ja) 2019-12-25

Family

ID=53493929

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016562455A Active JP6626454B2 (ja) 2014-01-06 2014-12-23 Trpa1モジュレーター

Country Status (10)

Country Link
US (2) US9951046B2 (enExample)
EP (1) EP3092228A4 (enExample)
JP (1) JP6626454B2 (enExample)
CN (1) CN106061969B (enExample)
AU (1) AU2014374043B2 (enExample)
CA (1) CA2936111C (enExample)
IL (1) IL246625B (enExample)
SG (1) SG11201605559VA (enExample)
WO (1) WO2015103060A1 (enExample)
ZA (1) ZA201605332B (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106061969B (zh) 2014-01-06 2019-10-29 阿尔戈么迪克斯有限公司 Trpa1调节剂
FI3381896T3 (fi) * 2015-11-27 2023-04-21 Taiho Pharmaceutical Co Ltd Bifenyyliyhdiste tai sen suola
CA3029901A1 (en) * 2016-07-06 2018-01-11 Algomedix, Inc. Trpa1 antagonists for treatment of dry eye, ocular pain and inflammation
CN106580984A (zh) * 2016-12-12 2017-04-26 高群 一种治疗高血脂症的药物组合物
JP7178357B2 (ja) * 2017-03-07 2022-11-25 エフ.ホフマン-ラ ロシュ アーゲー オキサジアゾール一過性受容器電位チャネル阻害剤
RU2765152C2 (ru) 2017-05-26 2022-01-26 Тайхо Фармасьютикал Ко., Лтд. Новое соединение бифенила или его соль
WO2018216795A1 (ja) * 2017-05-26 2018-11-29 大鵬薬品工業株式会社 新規なビフェニル化合物を用いた抗腫瘍効果増強剤
AU2018276611B2 (en) 2017-05-31 2022-01-06 Taiho Pharmaceutical Co., Ltd. Method for predicting therapeutic effect of LSD1 inhibitor based on expression of INSM1
CN109596818B (zh) * 2018-12-13 2024-03-19 丁蓉 一种基于电生理学分析当归四逆汤预防奥沙利铂神经毒性机制的研究方法
MX2022005811A (es) 2019-11-13 2022-06-08 Taiho Pharmaceutical Co Ltd Sal novedosa de compuesto de terfenilo.
JP7688339B2 (ja) * 2020-01-22 2025-06-04 国立研究開発法人理化学研究所 新規化合物、およびその利用
FR3114235A1 (fr) 2020-09-18 2022-03-25 Université Grenoble Alpes Inhibition du canal trpa1 astrocytaire comme nouvelle cible therapeutique neuroprotectrice dans les phases prodromales de la maladie d’alzheimer
CN112694436B (zh) * 2020-12-30 2022-07-08 济南周行医药科技有限公司 一种槟榔碱的合成方法
IT202100015098A1 (it) 2021-06-09 2022-12-09 Flonext S R L Composto antagonista del canale trpa1 per uso in patologie degenerative della retina
WO2024099404A1 (zh) * 2022-11-10 2024-05-16 北京普祺医药科技股份有限公司 一种含氮螺环类化合物、药物组合物以及其用途
CN121735827A (zh) * 2026-02-27 2026-03-27 泰励生物科技(上海)有限公司 哌啶酮类化合物的制备方法
CN121717751A (zh) * 2026-02-27 2026-03-24 泰励生物科技(上海)有限公司 手性哌啶酮类化合物的制备方法
CN121735881A (zh) * 2026-02-27 2026-03-27 泰励生物科技(上海)有限公司 砜类化合物的制备方法

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3575130D1 (de) * 1984-05-12 1990-02-08 Fisons Plc Antiinflammatorische 1,n-diarylpyrazol-3-amine, deren zusammensetzungen und verfahren zu deren herstellung.
GB8429128D0 (en) * 1984-11-17 1984-12-27 Fisons Plc Heterocyclic compounds
US6087381A (en) * 1997-05-22 2000-07-11 G. D. Searle & Company Pyrazole derivatives as p38 kinase inhibitors
WO1999058523A1 (en) * 1998-05-14 1999-11-18 G.D. Searle & Co. 1,5-DIARYL SUBSTITUTED PYRAZOLES AS p38 KINASE INHIBITORS
AU2004200420A1 (en) * 2003-03-11 2004-09-30 Astellas Pharma Inc. Inhibitor of cyclooxygenase
AU2004233827B2 (en) * 2003-04-24 2009-05-28 Merck Sharp & Dohme Corp. Inhibitors of Akt activity
RU2006117368A (ru) 2003-10-23 2007-12-10 Ф.Хоффманн-Ля Рош Аг (Ch) Производные триазаспиропипередина, предназначенные для применения в качестве ингибиторов glyt-1 при лечении неврологических и психоневрологических нарушений
CN1902191A (zh) * 2003-12-26 2007-01-24 第一制药株式会社 酰胺基吡唑衍生物
TW200526641A (en) * 2003-12-26 2005-08-16 Daiichi Seiyaku Co Amidopyrazole derivatives
GB0417910D0 (en) * 2004-08-11 2004-09-15 Novartis Ag Organic compounds
KR101363278B1 (ko) 2005-06-27 2014-02-21 엑셀리시스 페이턴트 컴퍼니 엘엘씨 이미다졸계 lxr 변조제
EP1962855B1 (en) 2005-12-22 2013-08-21 Hydra Biosciences, Inc. Trpa1 inhibitors for treating pain
US7977358B2 (en) 2007-07-26 2011-07-12 Hoffmann-La Roche Inc. Pyrazol derivatives
US8877784B2 (en) 2008-01-04 2014-11-04 Abbvie Inc. TRPA1 antagonists
JP5559156B2 (ja) 2008-06-02 2014-07-23 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ 3,4−ジヒドロピリミジンtrpa1アンタゴニスト
WO2010125469A1 (en) * 2009-04-29 2010-11-04 Glenmark Pharmaceuticals, S.A. Pyrimidinedione-fused heterocyclic compounds as trpa1 modulators
CA2773713A1 (en) 2009-10-07 2011-04-14 Merck Sharp & Dohme Corp. Novel trpa1 antagonists
US9133128B2 (en) 2011-06-17 2015-09-15 Research Triangle Institute Pyrazole derivatives as cannabinoid receptor 1 antagonists
DE102011055815A1 (de) 2011-11-29 2013-05-29 Aicuris Gmbh & Co. Kg Carboxamid-substituierte Heteroaryl-Pyrazole und ihre Verwendung
PE20150598A1 (es) 2012-10-01 2015-05-20 Orion Corp Derivados de n-prop-2-inil carboxamida y su uso como antagonistas del receptor transitorio potencial de la subfamilia a, miembro 1
CN106061969B (zh) 2014-01-06 2019-10-29 阿尔戈么迪克斯有限公司 Trpa1调节剂
CA3029901A1 (en) 2016-07-06 2018-01-11 Algomedix, Inc. Trpa1 antagonists for treatment of dry eye, ocular pain and inflammation

Similar Documents

Publication Publication Date Title
US11957657B2 (en) Combination therapies using immuno-dash inhibitors and PGE2 antagonists
HRP20140919T1 (hr) Spojevi koji moduliraju androgene receptore
RU2012121577A (ru) Замещенные 3-фенилпропионовые кислоты и их применение
JP2012521428A5 (enExample)
HRP20110456T1 (hr) Derivati indola kao agonisti receptora s1p1
HRP20211032T1 (hr) Postupci za uporabu agonista fxr
RU2014103587A (ru) Производные циклических аминов в качестве антагонистов рецептора ер4
JP2017518981A5 (enExample)
RU2012125372A (ru) Производные пиразола в качестве ингибиторов 11-бета-hsd1
RU2010136974A (ru) Способы лечения воспалительной боли
JP2013523746A5 (enExample)
EA201300342A1 (ru) Производные изоксазола и их применение в качестве потенциирующих средств для метаботропных глутаматных рецепторов
JP2017505293A5 (enExample)
RU2010102990A (ru) Производные оксадиазолов в качестве ингибиторов dgat
JP2022521955A5 (enExample)
US20230372372A1 (en) Combination therapies using caspase-1 dependent anticancer agents and pge2 antagonists
JP2025516005A5 (enExample)
JP2020505354A5 (enExample)
JP2015524470A5 (enExample)
RU2014102948A (ru) Вакцинная композиция для мукозального введения
JP2018536678A5 (enExample)
US20060217431A1 (en) Composition comprising a combined thromboxane receptor antagonist and thromboxane synthase inhibitor and a COX-2 inhibitor
PE20121403A1 (es) Nuevas sales de fumarato de un antagonista del receptor de histamina h3
JP2009504612A5 (enExample)
JP2012505225A5 (enExample)